Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT00095927Phase 2Completed
Randomized Amifostine For SCCHN
Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
Principalinvestigator
NCT00101075Phase 2Terminated
Title XELOX FOR SALIVARY GLAND CANCERS
Head and Neck Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Radiation ToxicityCancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of Head and NeckRadiation Toxicity

Worked with same sponsors:

AstraZenecaNational Cancer Institute (NCI)
Similarity Score12%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Cancer of Head and Neck
Similarity Score6%

Barbara Murphy, MD

Vanderbilt-Ingram Cancer Center

Related
14 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Charles L. Loprinzi, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Chemotherapeutic Agent Toxicity

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

AstraZenecaSanofi-Synthelabo
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00095875Phase 3StudyChair

Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)

Head and Neck Cancer
Completed
NCT00095927Phase 2PrincipalInvestigator

Randomized Amifostine For SCCHN

Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
Completed
NCT00101075Phase 2PrincipalInvestigator

Title XELOX FOR SALIVARY GLAND CANCERS

Head and Neck Cancer
Terminated

All 3 trials loaded